2023
Practitioner characteristics, diagnostic accuracy metrics and discovering-individual with respect to 637 melanomas documented by 27 general practitioners on the Skin Cancer Audit Research Database. Australasian Journal of Dermatology. 2023;64(3):378-388.
Validation of a microRNA liquid biopsy assay for diagnosis and risk stratification of invasive cutaneous melanoma. Br J Dermatol 2023;189:292-301.
2022
Real-time, in vivo skin cancer triage by laser-induced plasma spectroscopy combined with a deep learning-based diagnostic algorithm. Journal of the American Academy of Dermatology. 2022 June 22.
Perspectives and experiences of patient-led melanoma surveillance using digital technologies from clinicians involved in the MEL-SELF pilot randomised controlled trial: Qualitative Interview Study. JMIR Dermatology. 2022 Dec 20;5(4):e40623.
Development of melanoma clinical quality indicators for the Australian melanoma clinical outcomes registry (MelCOR): A modified Delphi study. Australasian Journal of Dermatology. 2022;62(3):344-351.
2021
Efficiency of Detecting New Primary Melanoma Among Individuals Treated in a High-risk Clinic for Skin Surveillance. JAMA Dermatology. 2021;157(5):521-530.
Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF): A Pilot Randomized Clinical Trial. JAMA Dermatology. 2021. doi:10.1001/jamadermatol.2021.4704.
Variability in the Histopathological Diagnosis of Non-Melanocytic Lesions Excised to Exclude Melanoma. Dematology Practical & Conceptual. 2021;11(4):e2021094.
Assessment of a Diagnostic Classification System for Management of Lesions to Exclude Melanoma. JAMA Network Open. 2021;4(12):e2134614.
Characteristics of 637 melanomas documented by 27 general practitioners on the Skin Cancer Audit Research Database. Australasian Journal of Dermatology. 2021;62(4):493-503.